ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Community Intervention Trial Reports

March 10, 1995

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

RFP Suggestions For Immunodiagnosis Research Offered

October 22, 1976

In Brief: CTRC Opens New Building With Ceremony For Survivors; WistarWins NASA Grant

June 9, 1995

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Waxman Introduces NIH Reauthorization, Kennedy To Follow

April 26, 1991